Apyx Medical Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.9% | -3.1% | -61.9% | -35.6% | -38.7% | -20.7% | -7.4% | -10.8% | -27.5% | -13.2% | -4.6% | -25.1% | -17.3% | |
| 1.6% | 1.0% | 1.5% | 1.3% | 1.3% | 1.0% | 1.5% | 1.2% | 1.3% | 1.2% | 1.6% | 1.4% | 1.3% | |
| 11.3% | 6.2% | 11.0% | 8.6% | 8.7% | 5.9% | 4.8% | 4.6% | 4.1% | 2.6% | 2.5% | 10.0% | 4.7% | |
| 53.8% | 15.4% | -3.1% | 5.8% | -3.4% | -2.8% | 27.5% | 11.4% | -21.1% | -14.4% | 6.3% | -15.0% | -11.6% | |
| 1.5% | 0.6% | 0.3% | 2.4% | 1.3% | 1.7% | 0.6% | 2.3% | 4.0% | 1.4% | 0.5% | 0.5% | 1.6% | |
| -1.5% | -0.6% | -0.3% | -2.4% | -1.3% | -1.7% | -0.6% | -2.3% | -4.0% | -1.4% | -0.5% | -0.5% | -1.6% | |
| – | – | – | – | 0.0% | 0.0% | -0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 1.4% | 150.7% | 0.0% | 0.0% | 0.0% | 47.5% | 0.3% | 0.2% | 0.3% | 49.5% | 0.7% | 0.0% | 16.4% | |
| 30.5% | 146.8% | -62.2% | -37.9% | -40.6% | 26.2% | -7.7% | -15.0% | -32.4% | 34.5% | -4.8% | -25.4% | -2.9% | |
| 29.4% | -3.8% | -62.2% | -38.0% | -40.0% | -22.4% | -8.0% | -13.2% | -31.5% | -14.6% | -5.1% | -25.6% | -18.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.